IVEX PROJECT

Not Applicable

• Conditions: Leprosy, Buruli Ulcer and Lymphatic Filariasis; Mental and Behavioural Disorders; Skin and Connective Tissue Diseases

• Registration Number: PACTR202404852537141
• Lead Sponsor: EFFECT HOPE CANADA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-12-05
• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Persons affected by leprosy, Buruli ulcer or Lymphatic filariasis including children with G2D, Category III BU lesions, BU complications such as contractures and other conditions (who need self-care)
Family members of persons affected by NTDs who give consent to participate
Persons affected by NTDs who are willing to learn and practice self-care
Consent to participate in SHG meetings of persons affected by leprosy, BU and LF

Exclusion Criteria

Persons who are unable to participate due to severe illness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improved well-being (physical, mental and socioeconomic) and quality of life of persons affected by NTDs in Nigeria

Secondary Outcome Measures

Name	Time	Method
Reduced stigma and discrimination related to NTDs;Improved morbidity management practices (physical and mental) for persons affected by NTDs;Strengthened health system through sustainable community participation in control of NTDs;Increased action by NTBLCP and NTD Units of the Federal Ministry of Health toward best practices in morbidity management of people affected by NTDs.